Biggest News Aggregation in the World
๐Ÿ“ฐ Present Status News

Page 2 - Present Status News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Present Status. Real-time updates on events, politics, business and more.

AstraZeneca: TAGRISSO achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial

Treatment with adjuvant TAGRISSO reduced the risk of death by more than half Positive results from the ADAURA Phase III trial showed AstraZeneca's TAGRISSO (osimertinib) demonstrated a statistically
United States United Kingdom Chelsea Ford Le Chevalier Daiichi Sankyo Brendan Mcevoy

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Tagrisso plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial

* Results support potential for a new treatment option that builds on the benefit of first-line standard of care Tagrisso monotherapy Positive high-level results from the FLAURA2 Phase III trial... | May 17, 2023
United States United Kingdom Daiichi Sankyo Astrazeneca Tagrisso Adrian Kemp Susan Galbraith

TAGRISSO® (osimertinib) plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial

Results support potential for a new treatment option that builds on the benefit of first-line standard of care TAGRISSO monotherapy ... | May 17, 2023
United Kingdom United States Susan Galbraith Daiichi Sankyo Archives Pathology Lab Dana Farber Cancer Institute

TAGRISSO® (osimertinib) demonstrated 5.5-year median disease-free survival in the adjuvant treatment of patients with EGFR-mutated lung cancer

Nearly three in four patients treated with adjuvant TAGRISSO were alive and disease-free at four years Exploratory results showed TAGRISSO also reduced the risk of disease recurrence in the brain or spinal cord by 76% in patients with Stage II-IIIA disease
United Kingdom Le Chevalier Provence Alpes Cรดd Azur United States France General Masahiro Tsuboi

The 20th Major General Samir Sinha Memorial Lecture was organised by the United Service Institution (USI) of India

New Delhi [India], August 31 (ANI/PNN): The 20th Major General Samir Sinha Memorial Lecture was organised by the United Service Institution (USI) of India on 30 August 2022, wherein Air Chief Marshal VR Chaudhari, PVSM, AVSM, VM, ADC, Offg Chairman, COSC and the Chief of the Air Staff delivered a talk on 'Transformation of the Indian Air Force: Present Status and the Way Ahead. Late Maj Gen Samir Chandra Sinha, PVSM, a stalwart paratrooper, scholar and visionary, was the revered Director of ...
New Delhi Aatmnirbhar Bharat Indian Air Transformation Of The Indian Air United Service Institution Major General Samir Sinha Memorial Lecture

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science